摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ZM 147376 | 131131-34-5

中文名称
——
中文别名
——
英文名称
ZM 147376
英文别名
4-nitro-3-trifluoromethyl-N-(2-hydroxy-2-p-nitro-phenylpropionyl)aniline;4-nitro-3-trifluoromethyl-N-(2-hydroxy-2-p-nitrophenylpropionyl)aniline;2-hydroxy-2-(4-nitrophenyl)-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
ZM 147376化学式
CAS
131131-34-5
化学式
C16H12F3N3O6
mdl
——
分子量
399.283
InChiKey
ALQKIFUMTRMSEL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    28
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    141
  • 氢给体数:
    2
  • 氢受体数:
    9

反应信息

  • 作为产物:
    描述:
    2-hydroxy-2-(4-nitrophenyl)propionic acid吡啶氯化亚砜 作用下, 反应 34.5h, 生成 ZM 147376
    参考文献:
    名称:
    Non-steroidal antiandrogens. Design of novel compounds based on an infrared study of the dominant conformation and hydrogen-bonding properties of a series of anilide antiandrogens
    摘要:
    Antiandrogenic activity is observed in anilides containing a tertiary hydroxyl group, and these compounds are used to define a pharmacophore in terms of their physicochemical properties. Infrared spectroscopy shows that these anilides exist in a single conformation, which exerts a powerful influence on the hydrogen-bond donor ability of the hydroxyl group in a model system. Arguments are presented which suggest that hydrogen-bonding ability is an important contributor to biological activity. Compounds were synthesized that reproduced these properties in series not containing an amide bond. Such compounds were found to exhibit good antiandrogen activity. We suggest that quantitative information on hydrogen bonding might also be useful in other systems.
    DOI:
    10.1021/jm00105a067
点击查看最新优质反应信息

文献信息

  • Amide derivatives, process for their manufacture and pharmaceutical or veterinary compositions containing them
    申请人:IMPERIAL CHEMICAL INDUSTRIES PLC
    公开号:EP0040932A1
    公开(公告)日:1981-12-02
    Novel 3,4-disubstituted-N-acylanilines of the formula: wherein Rl, R2 and ring A are defined in claim 1; wherein R3 is hydrogen or alkyl of up to 4 carbon atoms, or is joined to R5 as stated below; wherein R4 is alkyl of 2 to 4 carbon atoms, or has the formula -CX1X2X3 wherein X1, X2 and X3, which may be the same or different, each is hydrogen, fluorine or chlorine; wherein R5 is hydrogen, hydroxy or alkoxy or acyloxy each of up to 15 carbon atoms, or is joined to R3 to form an oxycarbonyl group such that together with the I -N-CO-C- part of the molecule it forms an oxazolidinedione group; and wherein R6 is hydrogen or halogen. These compounds possess antiandrogenic activity and are useful for the treatment of androgen dependent or prostatic diseases. Representative of the compounds is 3,4-dichloro-N-(2-hydroxy-2-p-nitrophenylpropionyl)aniline. Also disclosed are processes for the manufacture of the compounds and pharmaceutical and veterinary compositions containing them.
    式中的新型 3,4-二取代-N-酰基苯胺: 其中 Rl、R2 和环 A 在权利要求 1 中定义; 其中 R3 是氢或最多 4 个碳原子的烷基,或如下所述与 R5 连接; 其中 R4 是 2 至 4 个碳原子的烷基,或具有式 -CX1X2X3 其中 X1、X2 和 X3 可以相同或不同,各自是氢、氟或氯; 其中 R5 是氢、羟基或烷氧基或酰氧基,每个最多有 15 个碳原子,或与 R3 连接形成氧羰基,从而与分子的 I -N-CO-C- 部分一起形成噁唑烷二酮基团;以及 其中 R6 为氢或卤素。这些化合物具有抗雄激素活性,可用于治疗雄激素依赖性疾病或前列腺疾病。其中具有代表性的化合物是 3,4-二氯-N-(2-羟基-2-对硝基苯丙酰基)苯胺。此外,还公开了这些化合物的生产工艺以及含有这些化合物的药物和兽药组合物。
  • Use of estrogens or antiandrogens for reversal of male sexual phenotype in poultry
    申请人:MERCK & CO. INC.
    公开号:EP0514056A2
    公开(公告)日:1992-11-19
    Fertilized poultry embryos are treated with estrogens or antiandrogens or estrogens in combination with antiandrogens during a period of embryonic development when the gonads are bipotential. This treatment causes genetic males to exhibit a female phenotype. When sex reversed male birds are crossed with normal male birds all offspring will be genotypically male.
    受精的家禽胚胎在胚胎发育期间,性腺处于双潜能期,此时使用雌激素或抗雄激素,或雌激素与抗雄激素联合使用。这种处理方法会使遗传雄性表现出雌性表型。当性别逆转的雄性鸟类与正常雄性鸟类杂交时,所有后代的基因型都是雄性。
  • MORRIS, JEFFREY J.;HUGHES, LESLIE R.;GLEN, ALASDAIR T.;TAYLOR, PETER J., J. MED. CHEM., 34,(1991) N, C. 447-455
    作者:MORRIS, JEFFREY J.、HUGHES, LESLIE R.、GLEN, ALASDAIR T.、TAYLOR, PETER J.
    DOI:——
    日期:——
  • US4386080A
    申请人:——
    公开号:US4386080A
    公开(公告)日:1983-05-31
  • US5994362A
    申请人:——
    公开号:US5994362A
    公开(公告)日:1999-11-30
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐